Terms: = Germ cell tumor AND NF2, ACN, 4771, ENSG00000186575, P35240, SCH, Merlin, BANF AND Prognosis
59 results:
1. Sentinel lymph node risk prognostication in primary cutaneous melanoma through tissue-based profiling, potentially redefining the need for sentinel lymph node biopsy.
Kött J; Zimmermann N; Zell T; Rünger A; Heidrich I; Geidel G; Smit DJ; Hansen I; Abeck F; Schadendorf D; Eggermont A; Puig S; Hauschild A; Gebhardt C
Eur J Cancer; 2024 May; 202():113989. PubMed ID: 38518535
[TBL] [Abstract] [Full Text] [Related]
2. schisandrin B Inhibits cell Viability and Malignant Progression of Melanoma cells
Chen J; Zhang L; Pu Y; Chen Y; Li Y; Pan X; Chen J
Anticancer Agents Med Chem; 2023; 23(15):1765-1773. PubMed ID: 37622448
[TBL] [Abstract] [Full Text] [Related]
3. Cases of Mixed schwannoma-Meningioma With and Without Neurofibromatosis 2 with Emphasis on tumorigenesis.
Rajeswarie RT; Mallik D; Rudrappa S; Gopal S
Int J Surg Pathol; 2024 May; 32(3):511-514. PubMed ID: 37487199
[TBL] [Abstract] [Full Text] [Related]
4. [Rare tumor of internal auditory canal].
Yang BQ; Yang XL; Wu ZY; Wang L; Ren J; Wang WJ; Hua QQ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Jul; 57(7):843-847. PubMed ID: 35866277
[No Abstract] [Full Text] [Related]
5. Early prediction of functional prognosis in neurofibromatosis type 2 patients based on genotype-phenotype correlation with targeted deep sequencing.
Teranishi Y; Miyawaki S; Nakatomi H; Ohara K; Hongo H; Dofuku S; Okano A; Takayanagi S; Ota T; Yoshimura J; Qu W; Mitsui J; Morishita S; Tsuji S; Saito N
Sci Rep; 2022 Jun; 12(1):9543. PubMed ID: 35681071
[TBL] [Abstract] [Full Text] [Related]
6. Genetic testing to gain diagnostic clarity in neurofibromatosis type 2 and schwannomatosis.
Burns R; Niendorf K; Steinberg K; Mueller A; Ly I; Jordan JT; Plotkin SR; Hicks SR
Am J Med Genet A; 2022 Aug; 188(8):2413-2420. PubMed ID: 35638454
[TBL] [Abstract] [Full Text] [Related]
7. [Current Topics on Precision Medicine for Neurofibromatosis Type 2].
Hiruta R; Fujii M
No Shinkei Geka; 2022 Jan; 50(1):150-161. PubMed ID: 35169095
[TBL] [Abstract] [Full Text] [Related]
8. Genetic alterations associated with malignant transformation of sporadic vestibular schwannoma.
Håvik AL; Bruland O; Miletic H; Poulsgaard L; Scheie D; Fugleholm K; Lund-Johansen M; Knappskog PM
Acta Neurochir (Wien); 2022 Feb; 164(2):343-352. PubMed ID: 34816314
[TBL] [Abstract] [Full Text] [Related]
9. Revisiting the UK Genetic Severity Score for nf2: a proposal for the addition of a functional genetic component.
Catasús N; Garcia B; Galván-Femenía I; Plana A; Negro A; Rosas I; Ros A; Amilibia E; Becerra JL; Hostalot C; Rocaribas F; Bielsa I; Lazaro Garcia C; de Cid R; Serra E; Blanco I; Castellanos E;
J Med Genet; 2022 Jul; 59(7):678-686. PubMed ID: 34348961
[TBL] [Abstract] [Full Text] [Related]
10. Expression of Glutamine Metabolism-Related and Amino Acid Transporter Proteins in Adrenal Cortical Neoplasms and Pheochromocytomas.
Kim HM; Koo JS
Dis Markers; 2021; 2021():8850990. PubMed ID: 33505538
[TBL] [Abstract] [Full Text] [Related]
11. Posterior fossa ependymoma with preoperative cerebrospinal metastases: a case report with literature review.
Tang H; Wu T; Zhao F; Zhang J; Yang Z; Li P; Wang X; Wang B; Wang Z; Liu P
Br J Neurosurg; 2023 Oct; 37(5):1277-1280. PubMed ID: 33300386
[TBL] [Abstract] [Full Text] [Related]
12. Genetic alterations in non-syndromic, familial gliomas in first degree relatives: A systematic review.
Vasilica AM; Sefcikova V; Samandouras G
Clin Neurol Neurosurg; 2020 Nov; 198():106222. PubMed ID: 33039851
[TBL] [Abstract] [Full Text] [Related]
13. Sporadic vestibular schwannoma: a molecular testing summary.
Sadler KV; Bowers NL; Hartley C; Smith PT; Tobi S; Wallace AJ; King A; Lloyd SKW; Rutherford S; Pathmanaban ON; Hammerbeck-Ward C; Freeman S; Stapleton E; Taylor A; Shaw A; Halliday D; Smith MJ; Evans DG
J Med Genet; 2021 Apr; 58(4):227-233. PubMed ID: 32576656
[TBL] [Abstract] [Full Text] [Related]
14. Gene expression profiles between cystic and solid vestibular schwannoma indicate susceptible molecules and pathways in the cystic formation of vestibular schwannoma.
Yan S; Wang Q; Huo Z; Yang T; Yin X; Wang Z; Zhang Z; Wu H
Funct Integr Genomics; 2019 Jul; 19(4):673-684. PubMed ID: 30953268
[TBL] [Abstract] [Full Text] [Related]
15. cell-free circulating tumor DNA in patients with high-grade glioma as diagnostic biomarker - A guide to future directive.
Ahmed KI; Govardhan HB; Roy M; Naveen T; Siddanna P; Sridhar P; Suma MN; Nelson N
Indian J Cancer; 2019; 56(1):65-69. PubMed ID: 30950448
[TBL] [Abstract] [Full Text] [Related]
16. Malignant peripheral nerve sheath tumor: Transformation in a patient with neurofibromatosis type 2.
Agresta L; Salloum R; Hummel TR; Ratner N; Mangano FT; Fuller C; McMasters RL; Pater L; Jones BV; Szabo S; Pressey JG
Pediatr Blood Cancer; 2019 Feb; 66(2):e27520. PubMed ID: 30408304
[TBL] [Abstract] [Full Text] [Related]
17. Genetic Severity Score predicts clinical phenotype in nf2.
Halliday D; Emmanouil B; Pretorius P; MacKeith S; Painter S; Tomkins H; Evans DG; Parry A
J Med Genet; 2017 Oct; 54(10):657-664. PubMed ID: 28848060
[TBL] [Abstract] [Full Text] [Related]
18. Six cases of sporadic schwannomatosis: Topographic distribution and outcomes of peripheral nerve tumors.
Chick G; Victor J; Hollevoet N
Hand Surg Rehabil; 2017 Oct; 36(5):378-383. PubMed ID: 28781128
[TBL] [Abstract] [Full Text] [Related]
19. Co-occurring Mutations of tumor Suppressor Genes,
Tranchant R; Quetel L; Tallet A; Meiller C; Renier A; de Koning L; de Reynies A; Le Pimpec-Barthes F; Zucman-Rossi J; Jaurand MC; Jean D
Clin Cancer Res; 2017 Jun; 23(12):3191-3202. PubMed ID: 28003305
[No Abstract] [Full Text] [Related]
20. Genetic differences on intracranial versus spinal cord ependymal tumors: a meta-analysis of genetic researches.
Lee CH; Chung CK; Kim CH
Eur Spine J; 2016 Dec; 25(12):3942-3951. PubMed ID: 27637901
[TBL] [Abstract] [Full Text] [Related]
[Next]
